摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1'-(E)-[17-(5',5',6',6',7',7',8',8',9',9',10',10',10'-tridecafluoronon-1'-en-1'-yl)estra-3,17β-diol] | 1246639-05-3

中文名称
——
中文别名
——
英文名称
1'-(E)-[17-(5',5',6',6',7',7',8',8',9',9',10',10',10'-tridecafluoronon-1'-en-1'-yl)estra-3,17β-diol]
英文别名
(8R,9S,13S,14S,17R)-13-methyl-17-[(E)-4,4,5,5,6,6,7,7,8,8,9,9,9-tridecafluoronon-1-enyl]-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
1'-(E)-[17-(5',5',6',6',7',7',8',8',9',9',10',10',10'-tridecafluoronon-1'-en-1'-yl)estra-3,17β-diol]化学式
CAS
1246639-05-3
化学式
C27H27F13O2
mdl
——
分子量
630.489
InChiKey
LOIRLIXWFJQZTR-FAAAOKLOSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    8.8
  • 重原子数:
    42
  • 可旋转键数:
    7
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.7
  • 拓扑面积:
    40.5
  • 氢给体数:
    2
  • 氢受体数:
    15

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    17α-vinylestradiol3-(perfluorohexyl)prop-1-eneHoveyda-Grubbs catalyst second generation 作用下, 以 二氯甲烷 为溶剂, 反应 4.0h, 以19%的产率得到1'-(E)-[17-(5',5',6',6',7',7',8',8',9',9',10',10',10'-tridecafluoronon-1'-en-1'-yl)estra-3,17β-diol]
    参考文献:
    名称:
    Synthesis and Biochemical Characterization of a Series of 17α-Perfluoroalkylated Estradiols as Selective Ligands for Estrogen Receptor α
    摘要:
    Despite intensive research efforts, the distinct biological roles of two closely related estrogen receptors. FRG. and ER/beta, are only partially understood, Therefore, ligands selective for either of two isotypes are useful research tools because they allow for exerting a desired subset of biological effects mediated by only one of the receptors. Here we report on the synthesis of a new class of potent and selective ligands for ER alpha represented by a series of 17 alpha-substituted estradiols bearing lipophilic perfluoroalkyl chains. These 17 alpha-perfluoroalkylated estradiols were synthesized by Ru-catalyzed cross metathesis reactions 17 alpha-allyl- or 17 alpha-vinylestradiols with perfluoroalkylpropenes. Compounds were tested in both agonistic and antagonistic modes using a panel of stable steroid receptor reporter cell lines established in U2OS cells and consisting of ER alpha-LBD, ER/beta-LBD, GRLBD, and MR-LBD reporters. Some of the compounds are potent and selective agonists of ER alpha, exhibiting weak partial to no detectable agonistic activity on ER/beta. Notably, He is the most ER alpha selective ligand of the prepared compounds because it activates ER alpha, but inhibits ER/beta. In addition, some compounds are pure agonists on ER alpha, but show mixed agonistic/antagonistic profile on ER/beta which is a typical pattern observed for selective estrogen receptor modulators (SERMs).
    DOI:
    10.1021/jm100563h
点击查看最新优质反应信息

文献信息

  • Synthesis and Biochemical Characterization of a Series of 17α-Perfluoroalkylated Estradiols as Selective Ligands for Estrogen Receptor α
    作者:Barbara Eignerová、David Sedlák、Martin Dračínský、Petr Bartůněk、Martin Kotora
    DOI:10.1021/jm100563h
    日期:2010.10.14
    Despite intensive research efforts, the distinct biological roles of two closely related estrogen receptors. FRG. and ER/beta, are only partially understood, Therefore, ligands selective for either of two isotypes are useful research tools because they allow for exerting a desired subset of biological effects mediated by only one of the receptors. Here we report on the synthesis of a new class of potent and selective ligands for ER alpha represented by a series of 17 alpha-substituted estradiols bearing lipophilic perfluoroalkyl chains. These 17 alpha-perfluoroalkylated estradiols were synthesized by Ru-catalyzed cross metathesis reactions 17 alpha-allyl- or 17 alpha-vinylestradiols with perfluoroalkylpropenes. Compounds were tested in both agonistic and antagonistic modes using a panel of stable steroid receptor reporter cell lines established in U2OS cells and consisting of ER alpha-LBD, ER/beta-LBD, GRLBD, and MR-LBD reporters. Some of the compounds are potent and selective agonists of ER alpha, exhibiting weak partial to no detectable agonistic activity on ER/beta. Notably, He is the most ER alpha selective ligand of the prepared compounds because it activates ER alpha, but inhibits ER/beta. In addition, some compounds are pure agonists on ER alpha, but show mixed agonistic/antagonistic profile on ER/beta which is a typical pattern observed for selective estrogen receptor modulators (SERMs).
查看更多